Global Ganja Report

In the near future, the CBD, THC or other cannabinoids you consume in edibles or medications may not be derived from cannabis at all, but grown in a laboratory.

Kevin Chen, CEO and co-founder of Hyasynth Bio, describes the Montreal-based start-up as "focused on engineering strains of yeast to produce the active compounds of cannabis without having to grow plants."

Israel is a world leader in medical marijuana and has adopted an experimental decriminalization policy. But activists are pushing to make it the world's third country to outright legalize—and are using some very audacious tactics.

CBD products are now everywhere—health-food emporia, pharmacies, truck-stops. And pursuant to the 2018 Farm Bill, they are now legal—as long as the CBD is derived from “hemp” as opposed to what has traditionally been called “marijuana.” Hemp, as legally defined, is cannabis with under 0.3% THC—the psychoactive component of the plant, responsible for the long-stigmatized “high.”

But even the hempiest hemp—rope, not dope, as they used to say—usually has some THC.

Nancy Pelosi roused the ire of Mitch McConnell and anti-pot lobbyists when she defended inclusion of a measure to protect cannabis businesses in the House pandemic recovery bill. Does the science actually point to a therapeutic role for cannabis in treatment of COVID-19?

Cannabis advocates across the United States and the world bid a grateful farewell to Lester Grinspoon, the Harvard psychiatrist and prolific author who probably did more than any other individual to change the national conversation about marijuana, stressing the need for a more tolerant and enlightened policy.

As the so-called "Boomers" advance in years, they are using cannabis more, a new study reveals. What may have been a symbol of rebellion and the counterculture in their youth, is increasingly seen as medicine to help deal with the challenges of aging.

Growing numbers around the United States and the world are using cannabis to treat a wide spectrum of medical conditions, and legal space is widening for them to do so. So it's a particular irony that hospitals as a rule bar cannabis from their premises. More voices in the medical industry are now grappling with this dilemma.

A ground-breaking study is set to begin in Australia, to determine if cannabis can improve the quality of life of those suffering from dementia. Elderly care facilities are watching closely, hoping cannabis will prove a key to help those they look after lead happier lives, with less medication.